HealthInvestor Asia Summit 2018
Financial intelligence for Asia's healthcare markets
 
 
Remember me:

Analysis: How can healthcare development bonds help

The world’s first healthcare development impact bond aimed at reducing the number of maternal and newborn deaths in Rajasthan, India, launched last week.

Rajasthan has one of the highest maternal and newborn mortality rates in the country, with 244 maternal deaths per 100,000 births and 47 infant deaths per 1000 live births. The Maternal and Newborn Health DIB – known as the Utkrisht bond from the Hindi for “excellence” – will support government efforts to reduce maternal and newborn deaths by improving access to, and the quality of care in, up to 440 private healthcare facilities in Rajasthan.

For this impact bond, the upfront funder, UBS Optimus Foundation will provide up to US$3.5 million initial working capital so service providers can begin their work with private facilities in Rajasthan. It is the foundation’s second DIB in Rajasthan. It is currently running a three-year pilot DIB aimed at improving the education of girls.

Interventions will be delivered by NGOs Population Services International (PSI) and Indian non-profit organisation HLFPPT and will reach up to 600,000 pregnant women with improved care during delivery and could lead to up to 10,000 maternal and newborn lives being saved over a five year period. The impact bond was designed by advisory group Palladium, which will also manage implementation throughout the three-year term.

USAID and MSD for Mothers have committed US$8 million in outcome funding, provided a set of independently evaluated targets are met. The return on the bond is likely to be around 8%.

“This results-based financing mechanism is ground-breaking in that it takes a business approach to development, while still targeting basic needs like improving the quality of care and private facilities,” said administrator Mark Green, US Agency for International Development, at the launch of the impact bond. “By leveraging the assets and skills of a diverse group of partners across the public and private sectors, we are stretching our investments further while saving more lives. This mechanism is just one example of how USAID is doing business differently.”

Of course the success of the Utkrisht bond will be judged on whether healthcare facilities are able to achieve new certification standards, but this could pave the way for other impact bonds across southeast Asia.

“We need innovative and sustainable financing models to help solve some of development’s most vexing challenges,” said Karl Hofmann, president and CEO of Population Services International.

Posted on: 04/12/2017 UTC+08:00


News

Australian medtech company Medibio has signed a strategic partnership agreement with health technology services company Striiv.
Spanish molecular diagnostics company Genomica has opened its first subsidiary in Wuhan, China. The office, established in the East Lake High Tech Zone, will serve as an operations centre to increase the presence of the it parent, the PharmaMar Group not only in China, but also in other Asian-Pacific countries.
Shanghai-based mobile social platform The CareVoice, which is focused on the insurance industry, has raised US$2 million in its third round of seed funding led by venture capital firms SOSV and Haitao Capital.
Archie Fraser has stepped down as chief executive of Optiscan Imaging, which develops microscopic imaging technologies for medical markets, effective immediately. No reason for his resignation has been given.
Simon Lipscombe has resigned from his position as CEO of New Zealand’s Green Cross Health’s community health division. He has accepted the position of managing director of the New Zealand subsidiary of Compass Group, the world’s leading food and support services company.
Malaysian multinational PRG Holdings is moving into healthcare with the proposed acquisition of O&G focused private medical services provider Roopi Medical Centre for M$18.3 million (US$4.6 million) and a 25% stake in Esther Postpartum for M$3.75 million.
Union Medical Healthcare, the largest aesthetic medical service provider in Hong Kong, has mandated CMB International Capital as sole global coordinator and joint bookrunner with UBS and Haitong International to sell US dollar Reg S bonds.
It should surprise no one that the over-allotment option has been fully exercised by China Merchants Securities for Hong Kong ophthalmic company C-Mer Eye Care Holdings.



Analysis

The healthcare industry in Asia-Pacific is expected to grow at 11.1% in 2018, representing one of the fastest growing regions in the world, as the global healthcare economy averages a 4.8% annual growth rate.
Technologist, business leader, and philanthropist Bill Gates explains why global health needs the private sector.
Mitch Beaumont, Prashanth Prasad, Ulrica Sehlstedt and Mandeep Dhillon from international management consultants Arthur D. Little explain how medical technology companies can manage going digital.
Susann Roth, senior social development specialist, Asian Development Bank, argues why a health impact assessment is essential for hard infrastructure projects.
After a subdued 2017, healthcare mergers & acquisitions are expected to jump more than 80% this year in Asia Pacific to US$55.1 billion, according to global law firm Baker McKenzie.
After the Hong Kong High court found a doctor and a lab technician guilty of manslaughter, Michael Griffiths, regional director of healthcare at specialist insurance brokers Howden, looks at the extent of insurance or indemnity available to doctors in Asia accused of criminal acts.
Susann Roth, senior social development specialist, Asian Development Bank, looks at how Vietnam is building its digital health capacity.
The world’s first healthcare development impact bond aimed at reducing the number of maternal and newborn deaths in Rajasthan, India, launched last week.
my images

Podcasts

Hedge Fund Focus

HealthInvestor Asia twitter feed
HIA Indices